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Abstract
Background: Surgical site infections (SSIs) are the third most common hospital-associated infection and can lead to 
significant patient morbidity and healthcare costs. Identification of SSIs is key to surveillance and research but reliable 
assessment is challenging, particularly after hospital discharge when most SSIs present. Existing SSI measurement tools 
have limitations and their suitability for post-discharge surveillance is uncertain.
Aims: This study aimed to develop a single measure to identify SSI after hospital discharge, suitable for patient or 
observer completion.
Methods: A three-phase mixed methods study was undertaken: Phase 1, an analysis of existing tools and semi-struc-
tured interviews with patients and professionals to establish the content of the measure; Phase 2, development of ques-
tionnaire items suitable for patients and professionals; Phase 3, pre-testing the single measure to assess acceptability and 
understanding to both stakeholder groups. Interviews and pre-testing took place over 12 months in 2014–2015 with 
patients and professionals from five specialties recruited from two UK hospital Trusts.
Findings: Analyses of existing tools and interviews identified 19 important domains for assessing SSIs. Domains were 
developed into provisional questionnaire items. Pre-testing and iterative revision resulted in a final version with 16 items 
that were understood and easily completed by patients and observers (healthcare professionals).
Conclusion: A single patient and observer measure for post-discharge SSI assessment has been developed. Further 
testing of the validity, reliability and accuracy of the measure is underway.
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Introduction
Surgical site infection (SSI) is the third most common 
healthcare-associated infection (HCAI) to occur after sur-
gery (Smyth et al., 2008). Occurrence is associated with 
multiple factors, including patient co-morbidity, wound 
site, degree of contamination and whether surgery is per-
formed in the elective or emergency setting. Incidence may 
be as great as 40% (Anthony et al., 2011), being highest in 
unplanned procedures involving the gastrointestinal tract 
(Pinkney et al., 2013; Public Health England, 2014). SSI 
leads to significant morbidity (Whitehouse et al., 2002) and 
is the most common reason for unplanned readmission to 
hospital (Merkow et al., 2015). At worst, SSIs can even 
result in death (Coello et al., 2005). Ultimately, they can 
have major cost implications for health services (Jenks 
et al., 2014). Reduction of SSI is therefore of high priority 
to patients and to health services, and in the UK rates are 
routinely monitored for audit purposes in most National 
Health Service (NHS) Trusts. Consequently, it is essential 
that SSIs are accurately identified and measured for effec-
tive clinical governance and for research evaluating inter-
ventions to minimise SSI.
Commonly used tools to identify SSI include the 
Centres for Disease Control and Prevention (CDC) criteria 
and the ASEPSIS grading scale (Horan et al., 1992; Wilson 
et al., 1986). These tools, however, were developed pri-
marily for use in-hospital, in circumstances when most 
patients had post-operative hospital stays of several days. 
Experienced staff are required to complete the tools, yet 
they do not identify SSIs consistently (Gibbons et al., 
2011; Wilson et al., 2004). Problems with quantifying 
accurate incidence arise because many infections take time 
to develop and over 70% of SSIs may occur after the 
patient is discharged from hospital (National Institute for 
Health and Clinical Excellence, 2013; Petherick et al., 
2006; Wilson et al., 2013). This proportion is likely to 
increase as surgical techniques become less invasive and 
hospital stays get shorter. Post-discharge assessment of 
SSI by healthcare professionals is possible but relies on 
extensive resources and is expensive, requiring additional 
appointments to review the wounds (Tanner et al., 2009). 
One solution to improving post-discharge assessment is to 
use patient reported outcome measures, i.e. tools com-
pleted by patients themselves. Indeed, patient-reported 
modifications of the CDC criteria and ASEPSIS scale have 
been developed and are in use (Public Health England, 
2013; Wilson et al., 2013), yet these questionnaires were 
based on clinical and microbiological perspectives and 
were designed to capture similar information as in-hospital 
assessment. They have lacked patient input and have not 
been formally validated (Petherick et al., 2006). There is, 
therefore, a need to address these issues and design a 
measure for SSI that is appropriate for use after patients 
have been discharged from hospital. A suitably developed 
and validated tool for patient completion is needed, as well 
as a post-discharge assessment tool for healthcare profes-
sional use. However, the use of separate tools (i.e. for 
patient and observer completion) to assess the same out-
come may introduce the risk of a different underlying con-
struct being measured. A single measure that could be used 
by both patients and observers would ensure that the con-
tent validity is the same regardless of who is completing it. 
Such a measure may have potential applications in routine 
surveillance, research and clinical audit (Gibbons et al., 
2011).
The aim of this study, therefore, was to develop a relia-
ble single measure for SSI that can be used after the patient 
has been discharged from hospital and can be completed by 
the patient themselves and/or an observer.
Methods
Study design
This was a mixed methods study conducted in three phases 
using an existing framework for developing patient-centred 
outcome measures (Sprangers et al., 1993). Phases included: 
Phase 1, an analysis of existing tools and interviews with 
patients and professionals to establish the content of the 
measure; Phase 2, developing questionnaire items and 
designing an optimal tool; and Phase 3, cognitive inter-
views to pre-test the tool. Subsequent psychometric and 
diagnostic accuracy testing of the new measure will be 
described elsewhere.
Ethical approval was obtained from the NHS Health 
Research Authority NRES Committee London – Camden & 
Kings Cross (14/LO/0640). Written informed consent was 
obtained from all patients and professional participants.
Phase 1: establishing the content of the 
measure
Analysis of existing tools. A detailed analysis of the most 
commonly used tools (definitions and grading scales) for 
SSI assessment, identified by a previous systematic review 
(Bruce et al., 2001), was undertaken. The purpose was to 
ascertain relevant signs, symptoms and criteria for defining 
SSI to include in the new measure. Tools studied were the 
Public Health England (PHE) clinical criteria for SSI 
(based on the CDC criteria) and surgical wound healing 
post-discharge questionnaire for patients (Public Health 
England, 2013), and the ASEPSIS grading scale (Wilson 
et al., 1986) and associated post-discharge patient question-
naire (Gibbons et al., 2011; Wilson et al., 1990). Individual 
criteria or questionnaire items and their response categories 
were extracted and recorded verbatim. Criteria and items 
were grouped into SSI ‘domains’ based on the sign, symp-
tom or intervention to manage infection. Grouping was per-
formed by four authors (BCR, JMB, AN and RM) using 
methods for categorising health domains described previ-
ously (Macefield et al., 2014).
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Interviews with patients and professionals. Semi-structured 
interviews with patients with experience of SSI (n = 9) and 
professionals involved in post-surgical care (n = 10) were 
conducted to explore SSI signs, symptoms and interven-
tions for managing them, and to identify new domains not 
covered by the existing tools. Views on the existing PHE 
and ASPESIS tools were collected by asking participants to 
complete them during interviews and asking their opinion 
on their suitability, relevance and ease of completion. Pre-
designed interview topic guides were used to cover these 
objectives. Interviews were conducted by one researcher 
(AN), were audio-recorded and transcribed in full. Details 
on participant sampling are provided below.
Phase 2: designing the measure: 
‘operationalisation’ of domains and item 
development
Findings from Phase 1 were used to design a provisional 
new measure. Each of the SSI domains were operational-
ised into a questionnaire item according to standard pro-
cesses (Sprangers et al., 1993). Items were initially worded 
in lay language. Where the underlying domain could be 
described with a medical term, this word was included at 
the end of the item in parentheses. Medical terms were 
selected from existing tools or by the study team.
The single measure was designed as a questionnaire 
with two grammatical variations; one using the first-person 
context, i.e. ‘your wound’, appropriate for patient use, and 
another using the third-person context, i.e. referring to ‘the 
wound’, to be appropriate for observer completion.
Phase 3: pre-testing the measure
The provisional new measure was pre-tested in cognitive 
interviews. Patient participants (n = 28) who had undergone 
surgery were purposefully sampled (see below). 
Professional participants (n = 14) were recruited from pri-
mary care and secondary/tertiary care teams involved in 
surgical wound care. Patients were asked to complete the 
measure in relation to their own wound. Professionals were 
asked to use an example of a recent patient or a hypotheti-
cal case. Cognitive interviews assessed face validity, com-
prehension, suitability and acceptability. Interviews were 
conducted face-to-face with a researcher (RM or TM) at 
participants’ homes or places of work.
Participants were observed and asked to ‘think aloud’ 
while completing the questionnaire. Interviewers used 
probes to explore items further, such as “What does that 
word mean to you?” or “What do you interpret that word to 
mean?” (Beatty and Willis, 2007). Patients’ and profession-
als’ views on the inclusion of the medical terms used at the 
end of the items were explored. Participants were specifi-
cally asked about their understanding and perception of the 
medical description to ensure that the lay wording was an 
accurate and appropriate interpretation. Interviews were 
audio-recorded and summarised in descriptive 
memoranda.
Participants and sampling
Eligible patients had undergone abdominal general surgery 
or caesarean section from two participating UK hospital 
Trusts. Patients were identified and approached by research 
nurses and surgical trainees (NB, RB and DM) while in 
hospital. Phase 1 sampling was restricted to patients with 
confirmed or suspected SSI, identified before discharge or 
on readmission to hospital. Phase 3 sampling included 
patients who had undergone surgery within the previous 30 
days. Patient details were communication to other mem-
bers of the study team (AN, RM or TM) to contact and 
arrange subsequent interviews. Healthcare professionals 
involved in post-surgical care from the participating hospi-
tals were approached directly by members of the study 
team (AN and RM).
Participants were purposively sampled to include a 
range of sociodemographic characteristics and types of sur-
gery, and a range of clinical staff and expertise. Sampling 
and analysis for pre-testing the measure (Phase 3) was car-
ried out as an iterative process until no new themes emerged.
Data analyses
Phase 1: A descriptive table was used to map original items 
from the source documents (existing clinical tools and 
patient questionnaires) to the identified SSI domains 
(Table 1). Interview data were analysed using an inductive 
approach. Data were coded and grouped into similar themes 
(thematic content analysis) (Braun and Clarke, 2006). A 
descriptive account of the common identified themes was 
generated, including signs and symptoms of wound infec-
tion, follow-up care and treatment required, commonalities 
across specialties and feedback on the current measures of 
SSI. The account concluded with a summary of points to 
consider when developing the new measure.
Phase 3: Descriptive memoranda from the cognitive 
interviews included key findings or problems and sugges-
tions for modifications and improvements to the provisional 
measure; changes to items, response categories, formatting, 
instruction and layout. Obvious issues or repeated sugges-
tions were considered by the study team and edits were 
made in a new version of the measure. Data were analysed 
iteratively so that items could be modified, added or deleted 
to reflect emerging findings and allow further exploration of 
modifications in subsequent interviews.
At regular intervals throughout Phases 1–3, findings and 
versions of the measure were circulated to the immediate 
study team for comment and suggestions, and to the wider 
study team and collaborators before a large study meeting 
during Phase 2.
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Table 1. Identified SSI domains and mapping of criteria and items from existing tools.
SSI domain Criteria / Item from existing measure Source (existing tool)
Wound healing Have all of these wounds healed without any problem at all? ASEPSIS PQ
Have you had any problems with the healing of your wound? PHE PQ
Wound heat The area around the wound felt warmer/hotter than the surrounding skin PHE PQ
Heat PHE CDS
Wound redness Has the wound been red? ASEPSIS PQ
Redness or inflammation spreading from the edges of the wound PHE PQ
Erythema ASEPSIS CDS
 Redness PHE CDS
Wound discharge Has the wound discharged clear yellow fluid?
Has the wound discharged pus?
ASEPSIS PQ
ASEPSIS PQ
Purulent drainage PHE CDS
 Was there any discharge or leakage of fluid from any part of the wound?
If yes, was it either Clear or blood stained? Yellow/green (pus)? Other? - please 
specify
PHE PQ
 Serous discharge/serous exudate
Purulent exudate
ASEPSIS CDS
ASEPSIS CDS
Layers separating - 
spontaneous
Has the wound broken open? ASEPSIS PQ
The edges of any part of the wound separated or gaped open PHE PQ
 Separation of deep tissues ASEPSIS CDS
 Incision spontaneously dehisces [or opened by surgeon] PHE CDS
Wound swelling The area around the wound became swollen PHE PQ
 Localised swelling PHE CDS
Wound pain Pain or soreness in addition to the discomfort experienced following the 
operation
PHE PQ
 Localised pain and tenderness PHE CDS
Fever Fever (temperature 38ºC or more) PHE CDS
Contact with 
healthcare 
professional
If you saw a healthcare worker because of these symptoms, please indicate 
who you saw from the list (GP/district nurse/midwife/doctor or nurse at the 
hospital/other – please specify)
PHE PQ
Dressing needed Has a district nurse had to dress the wound? ASEPSIS PQ
Antibiotics needed Have you been given antibiotics for wound infection? ASEPSIS PQ
 Have you been prescribed antibiotics for an infection in the wound?
If yes, who prescribed them?________
PHE PQ
 Antibiotics prescribed ASEPSIS CDS
 Antibiotics prescribed by GP for SSI (patient reported only) PHE CDS
Layers separating - 
deliberate
Incision opened by surgeon [or spontaneously dehisces] PHE CDS
Hospital admission Have you been admitted to hospital elsewhere? ASEPSIS PQ
 Have you been readmitted to hospital with an infection of the surgical wound?
To the hospital at which the operation was carried out?
To another hospital?
PHE PQ
Drainage needed Drainage of pus under local anaesthesia (including vac therapy) ASEPSIS CDS
 Purulent drainage PHE CDS
(Continued)
Macefield 5
Results
Phase 1: establishing the content of the 
measure
Analysis of existing tools. A list of 42 items was generated 
from the PHE criteria, ASEPSIS grading scale and associ-
ated patient questionnaires. These were categorised and 
grouped to 18 domains; eight measuring SSI signs and 
symptoms and ten measuring wound management inter-
ventions (Table 1).
Interviews with patients and professionals. Participant demo-
graphics for the Phase 1 interviews are shown in Table 2. 
Patients (n = 9) had confirmed or suspected SSI after a 
range of gastrointestinal (GI) surgeries and professionals 
(n = 10) had various roles from GI, obstetric and paediatric 
specialties.
Interview data supported findings from the analysis of 
the existing measures. The following signs and symptoms 
were described as being indicative of infection: cellulitis 
or redness around the wound; discharge of pus; tender-
ness, pain or soreness of the wound; breakdown/opening 
of the wound; feeling generally unwell (often associated 
with a temperature or fever) and occasionally tachycardia 
(in two interviews with staff member in obstetrics); hot 
wound; abscess; swelling; and raised white blood cell 
count. The first three signs and symptoms were mentioned 
more frequently, without further questioning or prompt-
ing. Wound management care and interventions included: 
prescription of antibiotics; wound drainage; dressing 
changes; cleaning of wound; taking swabs/blood/imaging 
investigations; observation; consulting colleagues. It was 
possible to map interview data to the 18 domains identi-
fied in the existing tools. In addition, however, interview 
data identified ‘smell’ as a domain not currently measured 
in existing SSI tools. This was described by both patients 
and professionals.
Analysis of the existing tools and interviews therefore 
resulted in a total of 19 domains identified domains to con-
sider for inclusion in the new measure (Table 1).
Views on the current SSI tools and issues to consider for 
the new measure included simplification and use of lay lan-
guage, reducing the subjectivity of items and the need to 
distinguish varying SSI severity in the response categories. 
Confusion and misunderstanding emerged with some 
words used in existing tools including discharge, pus, 
abscess and antibiotics. There was a common tendency to 
talk about wound healing rather than wound infection. 
Filter questions often gave rise to responses that were con-
tradictory. For example, some participants responded that 
they had no problems with the healing of their wound (in 
answer to a filter question on one measure) yet responded 
that they had experienced some of the symptoms when 
asked to complete the rest of the measure.
Phase 2: designing the measure
A provisional new measure was designed based on the iden-
tified domains and findings from Phase 1. ‘Microbiology’ 
and ‘Prolonged hospital stay’ were excluded domains as 
they were considered to be inappropriate for a measure 
completed by a patient or observer after discharge and 
because such information is more suitably obtained from 
hospital records.
SSI domain Criteria / Item from existing measure Source (existing tool)
Wound cleaning Has the wound been opened and cleaned under general anaesthetic in hospital? ASEPSIS PQ
 Debridement of wound (general anaesthesia) ASEPSIS CDS
 Purulent drainage PHE CDS
Abscess Has a doctor opened/drained an abscess? ASEPSIS PQ
 Abscess or other evidence of infection found during a re-operation, by 
radiology or histopathology examination
PHE CDS
Microbiology Did any healthcare worker take a sample from your wound to send to the 
laboratory?
PHE PQ
 Aspirated fluid/swab of surgical site yields organisms and pus cells are present PHE CDS
 Isolation of bacteria ASEPSIS CDS
 SSI causative micro-organisms PHE CDS
Prolonged hospital 
stay
Stay as inpatient prolonged over 14 days ASEPSIS CDS
Smell – –
CDS, clinical data sheet; GP, general practitioner; PHE, Public Health England; PQ, patient questionnaire; SSI, surgical site infection.
Table 1. (Continued)
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Phase 3: pre-testing the measure
Interviewees were patients (n = 28) and healthcare profes-
sionals (n = 14) with a range of sociodemographics and 
expertise (Table 3). The mean time since patients’ surgery 
was 46 days (range, 6–208 days). Interviews lasted on aver-
age 27 min (range, 13–52 min).
Participants’ views on including medical terms along-
side lay language in a single measure were divergent. For 
example, some professionals raised concerns about includ-
ing medical terms in a questionnaire intended for patients 
because of the potential for generating worry or confusion, 
or that patients might be prompted to look up words on the 
Internet and see distressing images of serious cases. 
Generally, however, patients reported that the inclusion of 
medical terms in parentheses was acceptable with the 
majority paying attention only to the lay wording. Two 
patients reported that they might look up the medical term 
on the internet out of curiosity.
During pre-testing, interviews highlighted that the initial 
lay language description for some items had oversimplified 
the intended domain; the oversimplification only became 
apparent because a medical term had been included in 
parentheses. For example, the item intended to assess 
debridement of the wound (i.e. the medical removal of dead, 
damaged or infected tissue) was initially phrased ‘Has your 
wound been cleaned out? (debridement)’. However, pre-
testing found that different responses were given from par-
ticipants who read the lay language compared to those who 
read and understood the medical term. Some participants 
responded ‘yes’ to this item if the wound had been washed 
with saline solution or ‘superficially’ cleaned, whereas oth-
ers responded ‘yes’ only if dead or damaged tissue had been 
removed from the wound. Therefore, this item was modified 
to ‘Has your wound been scraped or cut to remove any 
unwanted tissue? (debridement)’. Interviews also identified 
items where the medical term as well as the lay description 
needed revising to accurately measure the intended domain. 
For example, the item initially phrased ‘Have the edges of 
any part of the wound separated? (dehiscence)’ was revised 
to ‘Have the edges of any part of the wound separated on 
their own accord? (spontaneous dehiscence)’ to distinguish 
it from interventions where the wound was opened up inten-
tionally by a doctor or nurse. These examples demonstrate 
that the inclusion of medical terms alongside lay language 
was beneficial during the development of the measure 
because it served as a grounding for the intended underlying 
construct.
The measure was modified throughout the pre-testing 
phase and eight versions were tested in subsequent inter-
views. Modifications included changes to the wording and 
structure of items, formatting, instructions and response cat-
egories. The final version consisted of 16 items, with nine 
including medical terms (Figure 1). Items relate to: (1) 
patient-reported signs or symptoms potentially indicative of 
SSI; and (2) patient-established information of wound care 
management and clinical interventions for treating SSI.
Discussion
This study developed a single measure for SSI assessment 
that can be completed after a patient has been discharged 
from hospital. It has been shown to be comprehensive, easy 
to complete and suitable for use by patients and observers 
(in this example, healthcare professionals). It is advanta-
geous for establishing information about SSI signs, symp-
toms and clinical interventions, irrespective of where the 
patient has received care during the SSI follow-up period. 
Describing items in lay language and with medical termi-
nology was found to reduce the risk of misinterpretation 
and ensured that the intended underlying domains were 
measured. The measure will now undergo full psychomet-
ric testing and assessment of diagnostic accuracy to deter-
mine its suitability for use in trials or post-discharge 
surveillance studies.
Existing commonly used measures for SSI are based on 
long-standing tools developed over 20 years ago. They 
were primarily designed for clinical use and did not include 
patients’ views during development; their adaptations as 
Table 2. Phase 1 participants: establishing the content of the 
measure.
Professionals 
(n = 10)
Patients 
(n = 9)
Gender Female 6 4
 Male 4 5
Role Consultant 5  
 Midwife 1  
 Nurse 1  
 Registrar 3  
Specialty Obstetrics 4  
 Paediatrics 3  
 Stoma care 1  
 Upper GI 2  
Type of 
surgery
Upper GI benign 2
Upper GI cancer 1
 Lower GI benign 3
 Lower GI cancer 1
 Appendicectomy 2
Wound 
infection
Confirmed 2
Suspected 1
 Absent 2
 Missing data 4
GI, gastrointestinal; GP, general practitioner.
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patient reported questionnaires were done with little 
reported validity and reliability testing (Petherick et al., 
2006). The new measure has been developed using thor-
ough methodology and followed an established framework 
for the development of outcome measures (Sprangers et al., 
1993). Mixed methods, including an examination of exist-
ing tools and interviews with patients and professionals, 
were used to inform the content of the measure and pre-test 
its acceptability. The current “dual-completion” (patient 
and observer) measure is a novel approach to outcome 
assessment, which traditionally employs multiple tools that 
have been developed separately and are used separately by 
patients and professionals. There are, however, some limi-
tations to this study. First, interviews were conducted with 
patients and professionals from a small number of surgical 
specialties where rates of SSI are known to be higher than 
others. Generalisation to other surgical categories is limited 
and we do not know how the questionnaire will perform in 
a wider population. The suitability of the measure for 
assessing SSI in other specialities, for example, orthopae-
dics, is unknown. Further work is required to validate the 
usefulness of the measure in a larger sample and wider 
population. Second, observers in the context of this study 
referred to healthcare professionals and completion by 
other observers (for example, carers) was not tested. The 
measure also has cultural limitations, and further testing of 
the wording and lay language descriptions in a more diverse 
population may be warranted. Third, the measure has been 
developed for use as a postal questionnaire. An electronic 
adaptation that could implement filter questions and be 
completed and returned as an online survey might have 
advantages for minimising the amount of missing data. 
Table 3. Phase 3 participants: pre-testing the measure.
Professionals (n = 14) Patients (n = 28)
Gender Female 10 11
 Male 4 17
Age at time of interview (years) 21–30 0 1
 31–40 7 2
 41–50 3 2
 51–60 3 6
 >60 1 17
Role Midwife 3 –
 Hospital/Research nurse 3 –
 Practice/Community nurse 1 –
 Surgical trainee 4 –
 GP 3 –
Specialty General practice/community 4 –
 Obstetrics 3 –
 Upper/Lower GI surgery 6 –
 Intensive care 1 –
Length of time qualified <10 1 –
 10-20 7 –
 >20 6 –
Time since surgery (weeks) <1 – 1
 1–2 – 2
 2–4 – 9
 >4 – 16
Type of surgery Upper GI – 9
 Lower GI – 10
 Caesarean – 3
 Hernia repair – 6
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Figure 1. Final version of the SSI measure after pre-testing.
 Since you left hospital after having surgery.... Response categories
1 Was there redness spreading away from the wound? (erythema/cellulitis) Not at all / A little / Quite a bit / A lot
2 Was the area around the wound warmer than the surrounding skin? Not at all / A little / Quite a bit / A lot
3 Was any part of the wound leaking fluid? Not at all / A little / Quite a bit / A lot
a) Was it clear fluid? (serous exudate) Not at all / A little / Quite a bit / A lot
b) Was it blood-stained fluid? (haemoserous exudate) Not at all / A little / Quite a bit / A lot
c) Was it thick and yellow/green fluid (pus/purulent exudate) Not at all / A little / Quite a bit / A lot
d) I do not know
4 Have the edges of any part of the wound separated/gaped open on their own 
accord? (spontaneous dehiscence)
Not at all / A little / Quite a bit / A lot
a) Did the skin separate? Not at all / A little / Quite a bit / A lot
b) Did the deeper tissue separate? Not at all / A little / Quite a bit / A lot
c) I do not know
5 Has the area around the wound become swollen? Not at all / A little / Quite a bit / A lot
6 Has the wound been smelly? Not at all / A little / Quite a bit / A lot
7 Has the wound been painful to touch? Not at all / A little / Quite a bit / A lot
8 Have you had, or felt like you have had, a raised temperature or fever? (fever 
<38oC)
Not at all / A little / Quite a bit / A lot
9 Have you sought advice because of a problem with your wound, other than at a 
routine planned follow-up appointment?
Yes / No
If yes, please tell us who you sought advice from:
a) A doctor or nurse at the GP surgery/medical centre/walk-in centre Yes / No
b) A doctor or nurse at the hospital Yes / No
c) A midwife or health visitor Yes / No
d) Another health advisor Yes / No
Please describe who the other health advisor was __________________
10 Has anything been put on the skin to cover the wound? (dressing) Yes / No
If yes, 
a) Was this done by a doctor or nurse at the GP surgery/ medical centre/walk-
in centre?
Yes / No
b) Was this done by a nurse/midwife/health visitor at home? Yes / No
c) Was this done by you/your partner/friend/family member? Yes / No
d) Was this done by a doctor/nurse/midwife at the hospital? Yes / No
e) Please describe what was put on to cover the wound __________________
11 Have you been back into hospital for treatment with a problem with your 
wound?
Yes / No
12 Have you been given antibiotics for a problem with you wound? Yes / No / Don’t know
If yes,
a) Were the antibiotics given as tablets/liquid? Yes / No / Don’t know
b) Were the antibiotics given via drip? Yes / No / Don’t know
If you know the name of the antibiotic(s) you have taken, please write it here 
__________________
13 Have the edges of your wound been deliberately separated by a doctor or 
nurse?
Yes / No / Don’t know
14 Has your wound been scraped or cut to remove any unwanted tissue? 
(debridement of wound)
Yes / No / Don’t know
15 Has you wound been drained? (drainage of pus/abscess) Yes / No / Don’t know
16 Have you had an operation under general anaesthetic for treatment of a 
problem with your wound?
Yes / No / Don’t know
Footnote: The version shown is for patient completion (with items written in first-person context).
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Finally, the measure has been designed for use after hospi-
tal discharge. If the measure is used during the initial hospi-
tal stay some of the items are redundant (e.g. ‘Have you 
been back into hospital for treatment of a problem with 
your wound?’).
The measure is currently being tested for validity and 
reliability in a larger sample of patients (approximately 400) 
undergoing abdominal surgery. How the responses from a 
completed questionnaire may be used to diagnose the pres-
ence/absence or type of SSI will be investigated in the anal-
ysis of the validation study and findings will be reported 
separately. Following validation and diagnostic accuracy 
testing, the suitability of the measure for collecting SSI out-
come data for research and routine surveillance can be eval-
uated. Future research using the new measure is intended in 
randomised controlled trials of interventions to reduce SSI.
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